Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments

Kwok, R., Tse, Y.‐K., Wong, G. L.‐H., Ha, Y., Lee, A. U., Ngu, M. C., Chan, H. L.‐Y., Wong, V. W.‐S.·2014·Alimentary Pharmacology & Therapeutics
DOI 10.1111/apt.12569

Cited by (401)

Items 201–300 of 401

  1. Identifying High-Risk NASH Patients: What We Know so Far
    Marten Schulz, Frank Tacke · 2020 · Hepatic Medicine Evidence and Research
  2. Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus
    Jaskamal Padda, Khizer Khalid, Anwar Khedr, Fahriba Tasnim, Ola A Al-Ewaidat, Ayden Charlene Cooper, Gutteridge Jean-Charles · 2021 · Cureus
  3. Practical approach to non‐alcoholic fatty liver disease in patients with diabetes
    Foong Way David Tai, Wing‐Kin Syn, William Alazawi · 2015 · Diabetic Medicine
  4. Noninvasive Diagnosis of Hepatic Steatosis Using Fat Attenuation Parameter Measured by FibroTouch and a New Algorithm in CHB Patients
    Hong Xin Deng, Chunling Wang, Jing Lai, Su-Lin Yu, Dong‐Ying Xie, Zhiliang Gao · 2016 · Hepatitis Monthly
  5. Position statement on the diagnosis and management of non-alcoholic fatty liver disease
    Khalid Alswat, Hind I. Fallatah, Bandar Al‐Judaibi, Hussien Elsiesy, Waleed Al-hamoudi, Adel N. Qutub, Naif Alturaify, Abdullah M. S. Al‐Osaimi · 2019 · Saudi Medical Journal
  6. ASMBS Position Statement on the Impact of Metabolic and Bariatric Surgery on Nonalcoholic Steatohepatitis
    Guilherme S. Mazzini, Toms Augustin, Sabrena F. Noria, Carlos Romero‐Marrero, Na Li, Bilal Hameed, Dan Eisenberg, Dan Elison Azagury, Sayeed Ikramuddin · 2021 · Surgery for Obesity and Related Diseases
  7. Performance of Real-Time Elastography for the Staging of Hepatic Fibrosis: A Meta-Analysis
    Huisuo Hong, Jia Li, Yin Jin, Qiao Li, Weimin Li, Jiansheng Wu, Zhiming Huang · 2014 · PLoS ONE
  8. Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus
    Zeinab Anwar El-Kabbany, Nancy Samir Elbarbary, Eman Abdel Rahman Ismail, Nesrine A Mohamed, Dina Ragab, Shereen Abdel Alem, Yasmine M Ezzat, Sarah S. Maurice, Noha Usama Hashem · 2016 · Journal of Diabetes and its Complications
  9. Noninvasive diagnostic tools for pediatric NAFLD: where are we now?
    Antonella Mosca, Nadia Panera, Annalisa Crudele, Anna Alisi · 2020 · Expert Review of Gastroenterology & Hepatology
  10. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound Elastography
    Monica Lupșor‐Platon, Teodora Serban, Alexandra Iulia Silion, Alexandru Tirpe, Mira Florea · 2020 · Cancers
  11. Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment
    Feryal Savari, Seyed Ali Mard · 2024 · Heliyon
  12. Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques
    Willy B. Theel, Bianca M. Boxma‐de Klerk, Femme Dirksmeier-Harinck, Elisabeth F. C. van Rossum, Danny A Kanhai, Jan A. Apers, Bas M. van Dalen, Robert Jacobus de Knegt, Adriaan Georgius Holleboom, Maarten E. Tushuizen et al. · 2022 · Obesity Reviews
  13. Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
    Georgiana-Emmanuela Gîlcă-Blanariu, Daniela Simona Budur, Dana Mitrică, Elena Gologan, Oana Timofte, Gheorghe Gh Bălan, VASILE-ANDREI OLTEANU, Gabriela Ștefănescu · 2023 · Metabolites
  14. A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease
    Wei‐Fan Hsu, Lee‐Yan Sheen, Hung‐Jen Lin, Hen‐Hong Chang · 2016 · Evidence-based Complementary and Alternative Medicine
  15. A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study
    Zhongwei Chen, Huanming Xiao, Xinjian Ye, Kun Liu, Rafael S. Rios, Kenneth I. Zheng, Yi Jin, Giovanni Targher, Christopher D. Byrne, Junping Shi et al. · 2021 · HepatoBiliary Surgery and Nutrition
  16. Non-Invasive Assessment of Non-Alcoholic Fatty Liver Disease: Ultrasound and Transient Elastography
    Annalisa Berzigotti · 2015 · Reviews on Recent Clinical Trials
  17. Potential use of metabolic breath tests to assess liver disease and prognosis: has the time arrived for routine use in the clinic?
    R. Todd Stravitz, Yaron Ilan · 2016 · Liver International
  18. A novel index including SNPs for the screening of nonalcoholic fatty liver disease among elder Chinese
    Huanhuan Yang, Guo‐Chong Chen, Chunli Song, Deming Li, Qinghua Ma, Guangliang Chen, Xinli Li · 2018 · Medicine
  19. Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
    Sumitro Kosasih, Wong Zhi Qin, Rafiz Abdul Rani, Nazefah Abdul Hamid, Chai Soon Ngiu, Shamsul Azhar Shah, Yazmin Yaakob, Raja Affendi Raja Ali · 2018 · International Journal of Hepatology
  20. Non‐invasive diagnosis of non‐alcoholic steatohepatitis and advanced fibrosis in Japan: A targeted literature review
    Yuichiro Eguchi, Gabriel Wong, Omar Akhtar, Yoshio Sumida · 2020 · Hepatology Research
  21. Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
    Ma Ai Thanda Han · 2020 · Life
  22. A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
    Hira Hanif, Muzammil Muhammad Khan, Mukarram Jamat Ali, Pir Ahmad Shah, Jinendra Satiya, Daryl Lau, Aysha Aslam · 2020 · Microorganisms
  23. Prospective evaluation of non-alcoholic fatty liver disease by elastographic methods of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements
    Ivana Mikolašević, Vesna Lukenda Žanko, Ivan Jakopčić, Viktor Domislović, Ana Mijić, Tajana Stevanović, Božena Delija, Tomislav Bokun, Petra Dinjar Kujundžić, Zvonimir Ostojić et al. · 2019 · Journal of Diabetes and its Complications
  24. Vibration-controlled Transient Elastography in NAFLD: Review Study
    Hasan Ozkan, Abdullah M Ozercan · 2022 · Euroasian Journal of Hepato-Gastroenterology
  25. Collaboration, Not Competition: The Role of Magnetic Resonance, Transient Elastography, and Liver Biopsy in the Diagnosis of Nonalcoholic Fatty Liver Disease
    Thomas Karlas, David Petroff, Johannes Wiegand · 2016 · Gastroenterology
  26. Ultrasonographic index for the diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease
    Jeong Woo Kim, Chang Hee Lee, Baek‐hui Kim, Young‐Sun Lee, Soon Young Hwang, Bit Na Park, Yang Shin Park · 2022 · Quantitative Imaging in Medicine and Surgery
  27. Fully connected neural network-based serum surface-enhanced Raman spectroscopy accurately identifies non-alcoholic steatohepatitis
    Feng Gao, Dechan Lu, Tianlei Zheng, Shi Geng, Jun‐Cheng Sha, Ou‐Yang Huang, Liang‐Jie Tang, Pei‐Wu Zhu, Yangyang Li, Lili Chen et al. · 2022 · Hepatology International
  28. Transient elastography with controlled attenuation parameter versus two-dimensional shear wave elastography with attenuation imaging for the evaluation of hepatic steatosis and fibrosis in NAFLD
    Jung Wook Seo, Youe Ree Kim, Jong Keon Jang, So Yeon Kim, Young Youn Cho, Eun Sun Lee, Dong Ho Lee · 2023 · ULTRASONOGRAPHY
  29. TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease
    Yusuf Nadir Yilmaz · 2023 · Hepatology forum/Hepatology forum (Online)
  30. How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?
    Joshua Trowell, Joseph J. Alukal, Talan Zhang, Li Liu, Anurag Maheshwari, Hwan Young Yoo, Paul Joseph Thuluvath · 2020 · Digestive Diseases and Sciences
  31. The role of elastography in non-alcoholic fatty liver disease
    Antonio Liguori, Maria Elena Ainora, Laura Riccardi, Nicoletta De Matthaeis, Fabrizio Pizzolante, Antonio Gasbarrini, Maria Assunta Zocco, Antonio Grieco, Gianludovico Rapaccini, Luca Miele · 2021 · Minerva Gastroenterology
  32. The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
    Ivana Mikolašević, Viktor Domislović, Irena Krznarić Zrnić, Željko Krznarić, Lucija Virović-Jukić, Sanja Stojsavljević, Ivica Grgurević, Sandra Milić, Ivan Vukoja, Petra Puž et al. · 2022 · Medicina
  33. Association between small dense LDL levels and hepatic fibrosis in patients with nonalcoholic fatty liver disease
    Sun‐Young Kim, Subin Mun, Jung Hwan Yu, Young‐Joo Jin, Young Ju Suh, Sang‐Heon Cho, Jin‐Woo Lee · 2022 · Medicine
  34. Imaging-Based Assessment of Steatosis, Inflammation and Fibrosis in NAFLD
    Timothy Hardy, Stuart McPherson · 2017 · Current Hepatology Reports
  35. Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
    Jennifer Gallacher, Stuart McPherson · 2018 · European Medical Journal
  36. Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus
    Ivana Mikolašević, Viktor Domislović, A. Ruzic, Goran Hauser, Dario Rahelić, S Klobucar-Majanovic, Željko Krznarić, Renata Dobrila-Dintinjana, Ivica Grgurević, Nadija Skenderević et al. · 2022 · Journal of Diabetes and its Complications
  37. Impact of obesity on liver function tests: is nonalcoholic fatty liver disease the only player? A review article
    Mervat M. El-Eshmawy · 2023 · Porto Biomedical Journal
  38. A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD
    Nimish Thakral, Hailemichael Desalegn, Luis Antonio Díaz, Daniel Cabrera, Rohit Seth Loomba, Marco A. Arrese, Juan Pablo Arab · 2024 · Seminars in Liver Disease
  39. Exploring non-invasive diagnostics for metabolic dysfunction-associated fatty liver disease
    Biao Qu, Zheng Li · 2024 · World Journal of Gastroenterology
  40. Serum Cytokeratin 18 Fragment Is an Indicator for Treating Metabolic Dysfunction-Associated Steatotic Liver Disease
    Miwa Kawanaka, Yoshihiro Kamada, Kazuhiro Takahashi, Michihiro Iwaki, Ken Nishino, Wenli Zhao, Yuya Seko, Masato Yoneda, Yoshihito Kubotsu, Hideki Fujii et al. · 2024 · Gastro Hep Advances
  41. Non-alcoholic fatty liver disease: A poorly known pandemic
    Salvador Augustín, Isabel Graupera, Juan Caballería · 2017 · Medicina Clínica (English Edition)
  42. Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis
    Monica A. Tincopa · 2020 · Endocrinology Diabetes & Metabolism
  43. Caspase-Cleaved Keratin 18 Measurements Identified Ongoing Liver Injury after Bariatric Surgery
    Felix Hempel, M Roderfeld, Lucas John Müntnich, Jens Albrecht, Ziya Oruc, Borros Michael Arneth, Thomas Karrasch, Jörn Pons‐Kühnemann, Winfried M. Padberg, Harald E. Renz et al. · 2021 · Journal of Clinical Medicine
  44. Management and diagnosis of fatty liver disease
    Amanda Schneier, Caitlin Citti, Douglas T. Dieterich · 2015 · Expert Review of Gastroenterology & Hepatology
  45. Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care
    Llorenç Caballería, Salvador Augustín, Teresa Broquetas, Rosa Maria Morillas, Mercedes Vergara, Silvia Virolés, Maria Rosa Hernández, Isabel Serra, Albert Goday, Lluís Vila et al. · 2019 · Medicina Clínica (English Edition)
  46. Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy
    Tavitiya Sudjaritruk, Torsak Bunupuradah, Linda Aurpibul, Pope Kosalaraksa, Nia Kurniati, Jiratchaya Sophonphan, Panruethai Trinavarat, Pannee Visrutaratna, Jiraporn Srinakarin, Nataruks Chaijitraruch et al. · 2019 · PLoS ONE
  47. Nonalcoholic fatty liver disease and elastography: Incremental advances but work still to be done
    William N. Hannah, Stephen A. Harrison · 2016 · Hepatology
  48. In search of new biomarkers for nonalcoholic fatty liver disease
    Ting‐Ting Chan, Vincent Wai‐Sun Wong · 2016 · Clinical Liver Disease
  49. Dapagliflozin Therapy Curative Effect Observation on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    Chen Hu, YU CHUAN . WANG, Yu Xi, XIN MING. YAO · 2020 · Indian Journal of Pharmaceutical Sciences
  50. Noninvasive imaging assessment of non-alcoholic fatty liver disease: Focus on liver scintigraphy
    Cristiane Valle Tovo, Ângelo Zambam de Mattos, Gabriela Perdomo Coral, Fernanda Branco, Eiji Suwa, Ângelo Alves de Mattos · 2015 · World Journal of Gastroenterology
  51. Serum microRNA-34a is potential biomarker for inflammation in nonalcoholic fatty liver disease
    Puth Muangpaisarn, Kanisa Jampoka, Sunchai Payungporn, Naruemon Wisedopas, Chalermrat Bunchorntavakul, Pisit Tangkijvanich, Sombat Treeprasertsuk · 2016 · Asian Biomedicine
  52. Obesity and Nonalcoholic Fatty Liver Disease
    Vanessa Bullón‐Vela, Itziar Abete, José Alfredo Martínez, M. Ángeles Zulet · 2018 · Elsevier eBooks
  53. Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
    Eddison Godinez Leiva, Fernando Bril · 2020 · Current Hypertension Reviews
  54. Development and Validation of a Novel Scoring System for Noninvasive Nonalcoholic Steatohepatitis Detection in Bariatric Patients
    Adrian Theophil Billeter, Sarah Wloka, Rouven Behnisch, Thomas Albrecht, Stephanie K. Roessler, Benjamin Frank Goeppert, Sebastian Mueller, Felix Nickel, Beat Peter Müller-Stich · 2021 · Obesity Facts
  55. Dual elastography to discriminate adjacent stages of fibrosis and inflammation in chronic hepatitis B: A prospective multicenter study
    Jianping Dou, Xi Chen, Cheng Guangwen, Meng Fankun, Zheng Ying, Zhang Bulin, Wei Zhang, Yao Zhang, Yin Zhiyong, Hong Yang et al. · 2023 · Hepatology
  56. The new definition of metabolic dysfunction-associated steatotic liver disease: the role of ultrasound and elastography
    Xinrui Jin, Terry Cheuk‐Fung Yip, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Jimmy Che‐To Lai · 2025 · ULTRASONOGRAPHY
  57. Ex vivo study of acoustic radiation force impulse imaging elastography for evaluation of rat liver with steatosis
    Yanrong Guo, Changfeng Dong, Haoming Lin, Xinyu Zhang, Huiying Wen, Yuanyuan Shen, Tianfu Wang, Siping Chen, Yingxia Liu, Xin Chen · 2016 · Ultrasonics
  58. Nonalcoholic fatty liver disease: use of diagnostic biomarkers and modalities in clinical practice
    Saleh A. Alqahtani, Jörn Markus Schattenberg · 2021 · Expert Review of Molecular Diagnostics
  59. Recent advances in NAFLD: current areas of contention
    Erica Jennison, Christopher D. Byrne · 2023 · Faculty Reviews
  60. Fatty Liver Disease and Food Insecurity: Excess in Scarcity
    Sujani Yadlapati, Vikram J. Christian, Apeksha Shah · 2023 · Current Nutrition Reports
  61. Non-invasive methods for diagnosing portal hypertension and variceal bleeding due to liver cirrhosis secondary to NAFLD/MASLD: systematic review
    Nebyu Yonas Shanka, Chavdar S Pavlov, Leul Mekonnen Nigatu · 2025 · Frontiers in Medicine
  62. Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver Disease
    Eunha Chang, Jae Seung Chang, In Deok Kong, Soon Koo Baik, Moon Young Kim, Kyu‐Sang Park · 2021 · Gut and Liver
  63. Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
    Yiwen Shi, Jian‐Gao Fan · 2022 · Clinical and Molecular Hepatology
  64. Non-Invasive Diagnostic of NAFLD in Type 2 Diabetes Mellitus and Risk Stratification: Strengths and Limitations
    Alina Mioara Boeriu, Daniela Ecaterina Dobru, Crina Fofiu · 2023 · Life
  65. The diagnostic conundrum in non-alcoholic fatty liver disease
    Valerio Rosato, Mario Masarone, Andrea Aglitti, Marcello Persico · 2020 · Exploration of Medicine
  66. Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity
    Valeria Calcaterra, Vittoria Carlotta Magenes, Matteo Vandoni, Clarissa Berardo, Luca Marin, Alice Bianchi, Erika Cordaro, Giustino Silvestro, Dario Silvestri, Vittoria Carnevale Pellino et al. · 2022 · Children
  67. Non‐alcoholic fatty liver disease in Asia: How is it different from the West?
    Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong · 2019 · Journal of Gastroenterology and Hepatology
  68. Suboptimal reliability of FIB‐4 and NAFLD‐fibrosis scores for staging of liver fibrosis in general population
    R. Hazzan, Nur Abu Ahmad, Abu Shqara Habib, Igbaria Saleh, Neeman Ziv · 2024 · JGH Open
  69. Non-Alcoholic Steatohepatitis: Clinical and Translational Research
    Manuela G. Neuman, M Voiculescu, Radu M. Nanau, Yaakov Maor, Ehud Melzer, Lawrence B. Cohen, Mihai Opris, Stephen D. H. Malnick · 2016 · Journal of Pharmacy & Pharmaceutical Sciences
  70. How to Identify the Patient with Nonalcoholic Steatohepatitis Who Will Progress to Cirrhosis
    Zachary H. Henry, Curtis Kent Argo · 2019 · Gastroenterology Clinics of North America
  71. Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after Successful Treatment with Direct-Acting Antivirals
    Napas Rodprasert, Tinn Hongboontry, Chitchanok Cherdchoochart, Roongruedee Chaiteerakij · 2023 · Medicina
  72. Personalizing Care for Nonalcoholic Fatty Liver Disease Patients: What are the Research Priorities?
    Silvia C. Sookoian, Carlos Jose Pirola · 2014 · Personalized Medicine
  73. Nonalcoholic Fatty Liver Disease
    Marie Boyle, Quentin Mark Anstee · 2019
  74. Diffuse Liver Diseases: Role of imaging
    Adele Taibbi, Dario Picone, Massimo Midiri, Ludovico La Grutta, Tommaso Vincenzo Bartolotta · 2017 · Seminars in Ultrasound CT and MRI
  75. Fibroscan® and Shear Wave correlated well in hepatic fibrosis evaluation of patients with chronic liver diseases “in real life situation”
    Honoré Zougmoré, Jean François David Cadranel, Gildas Fantognon, Badia Azzi, Ryad Smadhi, Jean René Ngele Efole, Samir Mrabti, Ratmony Heng, Marie-Adrien Ntsama, Mourad Medmoun et al. · 2022 · Medicine
  76. Nonalcoholic Fatty Liver Disease
    Carolin Lackner · 2018 · Elsevier eBooks
  77. The significance of IL-28B and CK-18 M30 levels in the diagnosis of non-alcoholic steatohepatitis in SD rats
    Guangrong Dai, Yue Tan, Jingjing Liu, Beibei Yuan, Qinglian Song, Jiaming Liu, Shuixiang He · 2020 · Pathology - Research and Practice
  78. Nonalcoholic Fatty Liver Disease
    Christopher Paul Day, Quentin Mark Anstee · 2015 · Seminars in Liver Disease
  79. Cytokeratin 18 in nonalcoholic fatty liver disease: value and application
    Yuan Shan Wu, Jing Zhou, Jun Zhang, Hongshan Li · 2024 · Expert Review of Molecular Diagnostics
  80. Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives
    Olga A. Sukocheva, Tsai‐Wing Ow, Damian Harding, Marc Le Mire, Edmund Tse · 2025 · World Journal of Hepatology
  81. Metabolic Dysfunction-Associated Steatohepatitis in Focus: Pathogenesis, Non-Invasive Diagnostics, and Future Approaches
    Abdulrahman Ismaiel, Mhd Bashir Almonajjed, Cristina-Sorina Cătană, Stefan‐Lucian Popa, Dan Lucian Dumitrascu · 2025 · Archives of Medical Research
  82. Liver magnetic resonance imaging, non-alcoholic fatty liver disease and metabolic syndrome risk in pre-pubertal Mexican boys
    Benito de Celis Alonso, Elizabeth Shumbayawonda, Cayden Beyer, Silvia Hidalgo-Tobón, Briseida López-Martínez, Pilar Dies-Suárez, Miguel Klünder‐Klünder, América Liliana Miranda‐Lora, Eduardo Barragán Pérez, Helena B. Thomaides-Brears et al. · 2024 · Scientific Reports
  83. Early diagnosis of NAFLD-NASH transition using mid infrared spectroscopy
    Siouar Bensaid, Amar Kachenoura, Nathalie Costet, Victor de Lédinghen, Julien Vergniol, Fabrice Lainé, Bruno Turlin, Hugues Tariel, Lotfi Senhadji · 2016 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
  84. Noninvasive Evaluation of Fibrosis and Steatosis in Nonalcoholic Fatty Liver Disease by Elastographic Methods
    Monica Lupșor‐Platon · 2018 · InTech eBooks
  85. Recruitment and Retention of Patients for Nonalcoholic Steatohepatitis Clinical Trials
    Mark H. DeLegge · 2020 · Gastroenterology Clinics of North America
  86. The Role of Elastography in Non-Alcoholic Fatty Liver Disease.
    Codruţa Constantinescu, Larisa Săndulescu, Adrian Săftoiu · 2020 · PubMed Central
  87. Debate—a bridge too far: Nonalcoholic fatty liver disease will not exhaust the donor pool
    Jacqueline G. O’Leary · 2014 · Liver Transplantation
  88. Meta‐analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease
    Yasushi Honda, Masato Yoneda, Takashi Kobayashi, Michihiro Iwaki, Nobuyoshi Kawamura, Asako Nogami, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Kento Imajo et al. · 2022 · Hepatology Research
  89. Cytokeratin-18 and Enhanced Liver Fibrosis Scores in Type 1 and Type 2 Diabetes and Effects of Two Different Insulins
    Arun Jayant Sanyal, Kenneth J. Cusi, Mark L. Hartman, Shuyu Zhang, Edward J. Bastyr, Juliana M. Bue‐Valleskey, Annette M. Chang, Axel Haupt, Scott J. Jacober, Robert J. Konrad et al. · 2017 · Journal of Investigative Medicine
  90. Elastography in the Diagnosis of Non-Alcoholic Fatty Liver Disease
    Elena N. Shirokova, Chavdar S Pavlov, Aleksandra Karaseva, Aliya M. Alieva, Alla Sedova, Vladimir T Ivashkin · 2019 · Annals of the Russian academy of medical sciences
  91. Transient Elastography Is the Best-Performing Non-Invasive Test of Liver Fibrosis in Obese Asian Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Cross-Sectional Study
    Kalaiyarasi Kaliyaperumal, Sanchalika Acharyya, Low Hsien Min, Yap Wei Ming, Vishal Girishchandra Shelat, Yew Kuo Chao, Low Jee Keem, Sameer Padmakumar Junnarkar, Huey Cheong Wei Terence, Tan Yen Ping · 2024 · Medicina
  92. Letter: accuracy of liver stiffness measurement – a comparison of two different FibroScan devices
    Jorge Parra-Ruiz, Carlos Sanjuan, Leopoldo Muñoz‐Medina, David Vinuesa García, Miriam Martínez-Pérez, José Hernández‐Quero · 2014 · Alimentary Pharmacology & Therapeutics
  93. Plasma Levels of K18 Fragments Do Not Correlate with Alcoholic Liver Fibrosis
    Viola Schlossberger, Mathias Worni, Christina Kihm, Matteo Montani, Christian Datz, Jochen Hampe, Felix Stickel · 2018 · Gut and Liver
  94. Non-alcoholic fatty liver disease: a multidisciplinary clinical practice approach—the institutional adaptation to existing Clinical Practice Guidelines
    Zoran M. Gluvic, Ratko Tomašević, Ksenija Bojović, Milan M. Obradovic, Esma R. Isenović · 2021 · Emergency and Critical Care Medicine
  95. Comprehensive Review on Biomarkers in Hepatotoxicity: From Conventional Indicators to Omics‑Driven Discoveries
    Shashikala Metri, Rohini Rasamallu, Ceema Mathew, Ganga Raju Mudunuri, Shaheda Mohammad · 2025 · Biosciences Biotechnology Research Asia
  96. Emerging Therapies and Therapeutic Targets for Composite Liver Disease: NASH
    Masilamani Elizabeth Sobhia, Sonia Kumari, Harish Kumar, Akshata Gandhe, Dhriti Kaushik, Harish Kumar, Jethender Jain, Ankita Ankita, Moyim Mallick, Bommana Pavani et al. · 2023 · Current Topics in Medicinal Chemistry
  97. Automatic Prediction of Non-alcoholic Liver Disease Using Deep Learning Models
    Uma N. Dulhare, Essam Halim Houssein · 2023 · Algorithms for intelligent systems
  98. Abdominelle Sonografie bei Patienten mit Diabetes mellitus. Teil 1: Leber
    Christian Jenssen, Cristine Pietsch, Urda Gottschalk, Ana Maria Barreiros, Andreas Teufel, Xin‐Wu Cui, C. F. Dietrich · 2015 · Zeitschrift für Gastroenterologie
  99. Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis
    Juan Macı́as, Pablo Parra Membrives, Francisco Sosa‐Moreno, Pilar Rincón, Darío Martínez-Baena, Marta Fernández‐Fuertes, José Manuel Lorente-Herce, Rafael C. Martinez, Granada Jiménez-Riera, Anaïs Corma‐Gómez et al. · 2022 · Scientific Reports
  100. Hígado graso no alcohólico en consulta de gastroenterología
    Edwin Ochoa C., Fredy H. Calambás · 2017 · Revista Repertorio de Medicina y Cirugía